Therapeutic Asset Ratings
6,308 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cetuximab
Nasopharyngeal Carcinoma
Hummingbird Bioscience
P1/2
CCC
(48)
Cetuximab Sarotalocan
Skin Squamous Cell Carcinoma
Rakuten Medical, Inc.
P1/2
CCC
(48)
Cetuximab Sarotalocan
Head And Neck Squamous Cell Carcinoma
Rakuten Medical, Inc.
P1/2
CCC
(48)
cg001419 tablets
NTRK Fusion Positive Cancer
Cullgen (Shanghai),Inc
P1/2
CCC
(48)
Chadox1-Magea3-Nyeso
Esophageal Squamous Cell Carcinoma
Cancer Research UK
P1/2
CCC
(48)
Chiauranib
Cancer
Chipscreen Biosciences, Ltd.
P1/2
CCC
(48)
Chimeric Antigen Receptor Modified T Cells Infusion
HER2 Positive Breast Carcinoma
National University Hospital, Singapore
P1/2
CCC
(48)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Chlorpromazine
Colon Carcinoma
Sadat City University
P1/2
CCC
(48)
CIS-DIAMMINEDICHLOROPLATINUM II
Malignant Peritoneal Mesothelioma
National Cancer Institute (NCI)
P1/2
CCC
(48)
CIS-DIAMMINEDICHLOROPLATINUM II
Pleural Disorder
Wuhan YZY Biopharma Co., Ltd.
P1/2
CCC
(48)
Cis-Dpi
Lung Cancer
Inhatarget Therapeutics
P1/2
CCC
(48)
CISH Inactivated Tumor Infiltrating Lymphocytes
Lung Adenocarcinoma
Intima Bioscience, Inc.
P1/2
CCC
(48)
CISH Inactivated Tumor Infiltrating Lymphocytes
Lung Large Cell Carcinoma
Intima Bioscience, Inc.
P1/2
CCC
(48)
Claudin18.2 Car-T Cells
Exocrine Pancreatic Carcinoma
Essen Biotech
P1/2
CCC
(48)
CLEMASTIN
Demyelinating Disease Of Central Nervous System
University of California, San Francisco
P1/2
CCC
(48)
CLEMASTIN
Chronic Progressive Multiple Sclerosis
University of California, San Francisco
P1/2
CCC
(48)
Clls52
B-Cell Non-Hodgkin Lymphoma
Cellectis S.A.
P1/2
CCC
(48)
CLOMIPHENE CITRATE
Drug Allergy
rana alaaeldin aly ibrahim nasr
P1/2
CCC
(48)
Cobicistat
Mixed Phenotype Acute Leukemia
Syndax Pharmaceuticals
P1/2
CCC
(48)
Cobolimab
Diffuse Intrinsic Pontine Glioma
GlaxoSmithKline
P1/2
CCC
(48)
Cobolimab
Glioblastoma
GlaxoSmithKline
P1/2
CCC
(48)
Cobolimab
Liver And Intrahepatic Bile Duct Neoplasm
GlaxoSmithKline
P1/2
CCC
(48)
Cobolimab
Glioma
GlaxoSmithKline
P1/2
CCC
(48)
cp-383
Head And Neck Squamous Cell Carcinoma
Tasca Therapeutics
P1/2
CCC
(48)
Showing 1001 to 1025 of 6,308 assets
Previous
Page 41 of 253
Next